Secondary Prevention Therapies in Real-World Patients with Myocardial Infarction: Eligibility Based on Randomized Trials Supporting European and American Guidelines-Reference-Cited by-同舟云学术

Secondary Prevention Therapies in Real-World Patients with Myocardial Infarction: Eligibility Based on Randomized Trials Supporting European and American Guidelines

Published:2024-02 Issue:2 Volume:137 Page:137-146.e10
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Mas-Llado Caterina,Rossello Xavier^ORCID,González-Del-Hoyo Maribel,Pocock Stuart,de Werf Frans Van,Chin Chee Tang,Danchin Nicolas,Lee Stephen W-L,Medina Jesús,Huo Yong,Bueno Héctor

Funder

AstraZeneca España

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. Achievements and limitations of evidence-based medicine;Desmond;J Am Coll Cardiol.,2016

2. The evidence supporting cardiovascular guidelines: is there evidence of progress in the last decade?;Bonow;JAMA.,2019

3. Mas-Llado C, González-Del-Hoyo M, Siquier-Padilla J, et al: Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines [e-pub ahead of print]. Eur Heart J Qual Care Clin Outcomes.https://doi.org/10.1093/EHJQCCO/QCAD007, accessed July 1, 2023.

4. Making sense of statistics in clinical trial reports: part 1 of a 4-part series on statistics for clinical trials;Pocock;J Am Coll Cardiol.,2015

5. Primary and secondary outcome reporting in randomized trials: JACC State-of-the-Art Review;Pocock;J Am Coll Cardiol.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure;European Journal of Heart Failure;2024-05-29

2. Mineralocorticoid receptor antagonist indication and underuse in high‐risk post‐myocardial infarction patients;European Journal of Heart Failure;2023-12-20

3. The dapagliflozin in patients with myocardial infarction (DAPA-MI) trial in perspective;European Heart Journal: Acute Cardiovascular Care;2023-11-18